Prospective, national , multicenter, and observational study.
To assess the incidence of AF in patients with cryptogenic stroke who have implanted an AF detection device during a period of 2 years.
Reveal XT 9529 (SQDM)
SAMPLE SIZE AND STUDY DURATION:
100 patients enrolled which will be followed during a period of 2 years.
Observational study in patients with cryptogenic stroke (TOAST criteria) and with an implanted EKG loop recorder, with the primary objective of knowing the atrial fibrillation incidence in this population
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample
Patients with cryptogenic stroke (TOAST criteria) and with an implantable EKG loop recorder implanted for detection of atrial fibrillation
|Type||Measure||Time Frame||Safety Issue|
|Primary||First AF episode detected by the implantable loop recorder in patients that had a cryptogenic stroke. An AF episode will be considered an AF episode that lasts at least 2 minutes.||Patients will be followed up during two years, regardless of reaching or not the primary endpoint.||No|
|Secondary||All subsequent AF episodes detected by the ILR after primary outcome (AF burden)||Patients will be followed up during two years||No|
|Secondary||AF episodes detected by external monitoring||Patients will be followed up during two years||No|
|Secondary||Presence of stroke, recurrent TIA, or silent infarction in neuroimaging||Patients will be followed up during two years||No|
|Secondary||Changes in anticoagulant therapy||Patients will be followed up during two years||No|